Press release
Giant-Cell Arteritis Market Size, Share Analysis And Growth Trends 2033
Giant-Cell Arteritis Market Size
As per the report, the giant-cell arteritis market size has grown steadily in recent years. It will grow from $1.02 billion in 2023 to $1.07 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. The giant-cell arteritis market size is expected to see strong growth in the next few years. It will grow to $1.30 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%.
Download Free Sample Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=17162&type=smp
What Is Driving The Growth Of The Global Giant-Cell Arteritis Market?
Embracing Personalized Medicine A Shift Towards Tailored Healthcare Solutions
Growing emphasis on personalized medicine is expected to propel the growth of the giant-cell arteritis market going forward. Personalized medicine involves tailoring medical treatment to individual characteristics, such as genetics, lifestyle, and environment. Personalized medicine is increasing due to advancements in genomics, biotechnology, and data analytics, enabling targeted therapies that improve treatment efficacy and reduce adverse effects for individuals. Personalized medicine can aid in giant-cell arteritis (GCA) by allowing for targeted therapies based on individual patient factors such as genetic predispositions, immune profiles, and disease manifestations
What Is The Key Trend In The Global Giant-Cell Arteritis Market?
Major Developments In Giant-Cell Arteritis Treatment
Major companies operating in the giant-cell arteritis are developing new products, such as biosimilar to expand treatment options and address the unmet medical needs of patients. A biosimilar is a biologic drug that is highly similar to an already approved biological product, with no clinically meaningful differences in terms of safety, purity, and potency.
How Is The Global Giant-Cell Arteritis Market Segmented?
The giant-cell arteritis market covered in this report is segmented -
1) By Therapeutics: Prednisone, Methotrexate, Tocilizumab, Aspirin
2) By Mechanism Of Action: Corticosteroids, Immunosuppressive Agents, Anticoagulants, Other Mechanisms Of Action
3) By Route Of Administration: Oral, Intravenous, Subcutaneous, Other Routes Of Administration
You Can Pre-Book The Global Market Report Of Your Requirement For A Swift Delivery And Also Get An Exclusive Discount On This Report, Checkout Link:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17162
How Is The Competitive Landscape Of The Global Giant-Cell Arteritis Market?
Major companies operating in the giant-cell arteritis market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., CSL Limited, Kiniksa Pharmaceuticals Ltd., MorphoSys AG
Contents Of The Global Giant-Cell Arteritis Market
1. Executive Summary
2. Giant-Cell Arteritis Market Report Structure
3. Giant-Cell Arteritis Market Trends And Strategies
4. Giant-Cell Arteritis Market - Macro Economic Scenario
5. Giant-Cell Arteritis Market Size And Growth
…..
27. Giant-Cell Arteritis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore The Report Store To Make A Direct Purchase Of The Report: https://www.thebusinessresearchcompany.com/report/giant-cell-arteritis-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Giant-Cell Arteritis Market Size, Share Analysis And Growth Trends 2033 here
News-ID: 3644453 • Views: …
More Releases from The Business research company
What Is Driving Global Kidney Dialysis Market Growth in 2025: The Role of Growin …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Kidney Dialysis Market Size Growth Forecast: What to Expect by 2025?
Considerable upward momentum has been observed in the renal dialysis sector's valuation recently; specifically, it is projected to expand from $85.65 billion in the year 2024 to reach $90.88 billion by 2025, reflecting a compound annual growth rate…
Comprehensive Idiopathic Pulmonary Fibrosis Market Forecast 2025-2034: Growth Tr …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Idiopathic Pulmonary Fibrosis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market valuation for idiopathic pulmonary fibrosis has shown robust expansion recently, moving from a figure of $4.15 billion in 2024 to an anticipated $4.37 billion by 2025, which reflects a steady compound annual…
The Rise In The Prevalence Of Skin Diseases : Powering Innovation and Expansion …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Hidradenitis Suppurativa Market Through 2025?
Recent years have witnessed robust expansion within the hidradenitis suppurativa market, which is projected to increase its valuation from $1.16 billion in 2024 to $1.24 billion the following year, reflecting a compound annual growth rate (CAGR) of…
2025-2034 Health Economics and Outcomes Research (HEOR) Services Market Outlook: …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Health Economics and Outcomes Research (HEOR) Services Industry Market Size Be by 2025?
The market encompassing health economics and outcomes research (HEOR) services has experienced swift expansion recently, projecting an increase from $1.57 billion in 2024 to $1.76 billion the following year, reflecting a compound annual…
More Releases for Arteritis
Giant Cell Arteritis Treatment Market: Global Trends, Growth, and Forecast 2025- …
The giant cell arteritis treatment market is witnessing significant traction with the increasing awareness of autoimmune disorders and the rising healthcare expenditure globally. The market, which was valued at USD 147.50 million in 2024, is projected to expand at a CAGR of 5.20% during the forecast period of 2025 to 2034, reaching a value of USD 244.88 million by 2034. With the growing geriatric population-particularly those above 50 years old-who…
Giant Cell Arteritis Treatment Market Size, Share, Industry Growth 2032
Giant Cell Arteritis Treatment Market Overview
Giant Cell Arteritis (GCA) is a systemic vasculitis condition that causes inflammation of the blood vessels, primarily affecting the large arteries in the head, such as the temporal arteries. The global Giant Cell Arteritis Treatment Market is driven by rising healthcare expenditure and increased awareness of autoimmune diseases. Treatments focus on reducing inflammation, controlling symptoms, and preventing complications, primarily using corticosteroids and other immunosuppressive therapies.…
Giant-Cell Arteritis Market Scope, Share, Trends Analysis And Forecasts(2024 - 2 …
"The Business Research Company recently released a comprehensive report on the Global Giant-Cell Arteritis Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Giant Cell Arteritis Therapeutics Market Forecast 2024-2030: Advances in Treatme …
Breakthrough Treatment for Giant Cell Arteritis Sparks Surge in Global Market Valuation
Giant Cell Arteritis, a prevalent form of systemic vasculitis affecting individuals over 50, is witnessing a paradigm shift in its treatment landscape. The condition, characterized by granulomatous medium and large-vessel inflammation, is most common among Caucasians, particularly those in Scandinavian countries and of northern European descent. However, the European market is anticipated to experience accelerated growth, challenging previous demographic…
Global Giant Cell Arteritis Treatment Market Forecast 2023-2028 Under Inflation
This Giant Cell Arteritis Treatment market report assists major companies in generating revenues by making the appropriate investments and taking the necessary actions to alter perceptions. It addresses compliance hurdles as well as future possibilities as a whole. By adhering to these business indicators, industries may create goals for their businesses, overcome the competition, follow strategic goals, and, as a result, make large profits. It allows businesses to take a…
Giant Cell Arteritis Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Giant Cell Arteritis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Giant Cell Arteritis , historical and forecasted epidemiology as well as the Giant Cell Arteritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Giant Cell Arteritis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and…
